glp 1 journey 26f, 5'1 or striving to maintain your progress GLP-1 Agonists - What is

Description

The incubation of human atrial cardiomyocytes with canagliflozin reduced inflammation and apoptosis, suppressing myocardial NADPH oxidase activity, and improved nitric oxide synthase (NOS) coupling via SGLT1/AMPK/Rac1 signaling [112]

However, there is a growing interest in using Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) in PCOS due to their efficacy in weight loss, insulin resistance, and heart health

9 Research gaps and future priorities 9.1 Reproductive-oriented RCTs: shifting from metabolic surrogates to hard endpoints To date, most GLP-1RA trials in PCOS have been designed around metabolic efficacy (weight change and insulin-resistance/glycaemic indices) as the primary outcomes, with reproductive outcomesovulation, clinical pregnancy, and live birthreported inconsistently and often as secondary or exploratory measures

A study published in JAMA found that individuals using GLP-1 receptor agonists had a higher incidence of gallbladder-related problems compared to those on placebo